Abstract
Background
Because it is not metabolized as is norepinephrine (NE), most of the metaiodobenzylguanidine (MIBG) taken up by the heart is considered to be lost subsequently by release concomitant with sympathetic stimulation. Therefore we examined whether the washout of MIBG is influenced by sympathetic tone, which we modulated by using immobilization stress or activation of the renin-angiotensin system (RAS).
Methods and Results
In 175 male ddY mice, left ventricular radioactivity was counted 30 minutes or 4 hours after injection of 74 kBq (2 μCi) of iodine 125- or iodine 131-labeled MIBG (125I- or 131I-MIBG). The washout rates of MIBG were determined under immobilization stress or under sodium loading or restriction in combination with losartan (10 mg/kg) or cilazapril (1 mg/kg) pretreatment. Immobilization enhanced the washout of 125I-MIBG (80.9% vs 57.9% in the control animals); this was determined to be related to washout from the neuronal compartment, because the nonneuronal component assessed through desipramine pretreatment was not affected. Pretreatment with losartan or cilazapril decreased the facilitation of 125I-MIBG washout in sodium-restricted mice (40.9% and 33.7%, respectively, vs 43.5% in the control animals), but not in sodium-loaded mice.
Conclusions
Measurement of MIBG washout may be feasible for determining the changes in sympathetic tone caused by immobilization stress or activation of the RAS.
Similar content being viewed by others
References
Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclinical heart failure: remodeling and the potential intervention. Circulation 1993;87(Suppl IV):IV90-IV96.
Swedberg K, Viquerat C, Rouleau J, et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol 1984;54:783–6.
Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993;83:136–45.
Wieland DM, Wu J, Brown LE, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22–31.
Merlet P, Valette H, Dubois-Rande J, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–7.
Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192–9
Dae MW, Marco TD, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts—implications for clinical studies. J Nucl Med 1992;33:1444–50.
Rabinovitch MA, Rose CP, Schwab AJ, et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993;34:589–600.
Sole MJ, Lo C, Laird CW, Sonnenblick EH, Wurtman RJ. Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ Res 1975;37:855–62.
Richardt G, Mayer E, Schomig A. Role of angiotensin and sodium intake in cardiac noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol 1991;344:297–301.
Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620–4.
Chiu AT, McCall DE, Price WA, et al. Nonpeptide angiotensin II receptor antagonists, VII: cellular and biochemical pharmacology of Dup 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1989;252:711–7.
Trendelenbeurg U. The extraneuronal uptake and metabolism of catecholamines in the heart. In: Paton DM, ed. The mechanism of neuronal and extraneuronal transport of catecholamines. New York: Raven Press, 1976:259–80.
Jaques S, Tobes MC, Sisson JC. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res 1987;47:3920–8.
Mock BH, Tuli MM. Influence of specific activity on myocardial uptake of 123I-MIBG in rats. Nucl Med Commun 1988;9:663–7.
Majewski H, Hedler L, Starke K. The noradrenaline release rate in the anaesthetized rabbit: facilitation by adrenaline. Naunyn Schmiedebergs Arch Pharmacol 1982;321:20–7.
Schlant RC, Sonnenblick EH. Pathophysiology of heart failure. In: Hurst IW, Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK. eds. The heart. 7th ed. New York: McGraw-Hill, 1993:387–417.
Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986;27:84–9.
Curtiss C, Cohn JN, Vrobel T, et al. Role of the reninangiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978;58:763–70.
Lee MA, Bohm M, Paul M, Ganten D. Tissue reninangiotensin systems: their role in cardiovascular disease. Circulation 1993;87(Suppl):IV7-IV13.
Hughes J, Roth RH. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmac 1971;41:239–55.
Antonaccio MJ, Kerwin L. Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats. Eur J Pharmacol 1980;68:209–12.
Khairallah PA. Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc 1972;31:1351–7.
The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429–35.
Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173–8.
Francis GS, Benedict C, Johnstone DE, et al. for the SOLVD investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724–9.
Sloman G. for the Australian Zestril (Lisinopril) Study Group. Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. Am J Cardiol 1992;70:113C-8C.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takatsu, H., Scheffel, U. & Fujiwara, H. Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle-influence of immobilization stress and inhibition of the renin-angiotensin system. J Nucl Cardiol 2, 507–512 (1995). https://doi.org/10.1016/S1071-3581(05)80043-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/S1071-3581(05)80043-1